Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
JAMA Psychiatry March 29, 2023 Sarah Mcnamee, Neşe Devenot, Meaghan Buisson 167 citations
Serious adverse events in psychedelic-assisted therapy trials can arise from interactions between therapists and patients. This Viewpoint discusses such events, highlighting the importance of therapeutic relationship dynamics in ensuring participant safety.